Your browser doesn't support javascript.
loading
The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-Like Phenotype.
Vandamme, Niels; Denecker, Geertrui; Bruneel, Kenneth; Blancke, Gillian; Akay, Özden; Taminau, Joachim; De Coninck, Jordy; De Smedt, Eva; Skrypek, Nicolas; Van Loocke, Wouter; Wouters, Jasper; Nittner, David; Köhler, Corinna; Darling, Douglas S; Cheng, Phil F; Raaijmakers, Marieke I G; Levesque, Mitchell P; Mallya, Udupi Girish; Rafferty, Mairin; Balint, Balazs; Gallagher, William M; Brochez, Lieve; Huylebroeck, Danny; Haigh, Jody J; Andries, Vanessa; Rambow, Florian; Van Vlierberghe, Pieter; Goossens, Steven; van den Oord, Joost J; Marine, Jean-Christophe; Berx, Geert.
Afiliação
  • Vandamme N; Molecular and Cellular Oncology Laboratory, Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
  • Denecker G; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Bruneel K; VIB-UGent Center for Inflammation Research, Ghent, Belgium.
  • Blancke G; Molecular and Cellular Oncology Laboratory, Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
  • Akay Ö; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Taminau J; Molecular and Cellular Oncology Laboratory, Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
  • De Coninck J; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • De Smedt E; Molecular and Cellular Oncology Laboratory, Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
  • Skrypek N; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Van Loocke W; Molecular and Cellular Oncology Laboratory, Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
  • Wouters J; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Nittner D; VIB-UGent Center for Inflammation Research, Ghent, Belgium.
  • Köhler C; Laboratory for Molecular Cancer Biology, VIB Center for Cancer Biology, Leuven, Belgium.
  • Darling DS; Laboratory for Molecular Cancer Biology, Department of Oncology, KULeuven, Leuven, Belgium.
  • Cheng PF; Molecular and Cellular Oncology Laboratory, Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
  • Raaijmakers MIG; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Levesque MP; Molecular and Cellular Oncology Laboratory, Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
  • Mallya UG; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Rafferty M; Molecular and Cellular Oncology Laboratory, Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
  • Balint B; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Gallagher WM; Molecular and Cellular Oncology Laboratory, Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
  • Brochez L; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Huylebroeck D; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
  • Haigh JJ; Center for Medical Genetics, Department of Biomolecular Medicine, Ghent University and University Hospital, Ghent, Belgium.
  • Andries V; Laboratory of Translational Cell and Tissue Research, Department of Pathology, KULeuven and UZ Leuven, Leuven, Belgium.
  • Rambow F; Laboratory for Molecular Cancer Biology, VIB Center for Cancer Biology, Leuven, Belgium.
  • Van Vlierberghe P; Laboratory for Molecular Cancer Biology, Department of Oncology, KULeuven, Leuven, Belgium.
  • Goossens S; Laboratory for Molecular Cancer Biology, VIB Center for Cancer Biology, Leuven, Belgium.
  • van den Oord JJ; Laboratory for Molecular Cancer Biology, Department of Oncology, KULeuven, Leuven, Belgium.
  • Marine JC; Department of Oral Immunology and Infectious Diseases, and Center for Genetics and Molecular Medicine, University of Louisville, Louisville, Kentucky.
  • Berx G; Department of Dermatology, University of Zurich, University of Zurich Hospital, Zurich, Switzerland.
Cancer Res ; 80(14): 2983-2995, 2020 07 15.
Article em En | MEDLINE | ID: mdl-32503808
ABSTRACT
Epithelial-to-mesenchymal transition (EMT)-inducing transcription factors (TF) are well known for their ability to induce mesenchymal states associated with increased migratory and invasive properties. Unexpectedly, nuclear expression of the EMT-TF ZEB2 in human primary melanoma has been shown to correlate with reduced invasion. We report here that ZEB2 is required for outgrowth for primary melanomas and metastases at secondary sites. Ablation of Zeb2 hampered outgrowth of primary melanomas in vivo, whereas ectopic expression enhanced proliferation and growth at both primary and secondary sites. Gain of Zeb2 expression in pulmonary-residing melanoma cells promoted the development of macroscopic lesions. In vivo fate mapping made clear that melanoma cells undergo a conversion in state where ZEB2 expression is replaced by ZEB1 expression associated with gain of an invasive phenotype. These findings suggest that reversible switching of the ZEB2/ZEB1 ratio enhances melanoma metastatic dissemination.

SIGNIFICANCE:

ZEB2 function exerts opposing behaviors in melanoma by promoting proliferation and expansion and conversely inhibiting invasiveness, which could be of future clinical relevance. GRAPHICAL ABSTRACT http//cancerres.aacrjournals.org/content/canres/80/14/2983/F1.large.jpg.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Regulação Neoplásica da Expressão Gênica / Proliferação de Células / Transição Epitelial-Mesenquimal / Homeobox 2 de Ligação a E-box com Dedos de Zinco / Neoplasias Pulmonares / Melanoma Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Regulação Neoplásica da Expressão Gênica / Proliferação de Células / Transição Epitelial-Mesenquimal / Homeobox 2 de Ligação a E-box com Dedos de Zinco / Neoplasias Pulmonares / Melanoma Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article